SOL 802
Alternative Names: SOL-802Latest Information Update: 07 Sep 2023
At a glance
- Originator SOLA Biosciences
- Class Gene therapies
- Mechanism of Action Gene transference
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Research Unspecified
Most Recent Events
- 25 Jul 2023 Early research in Unspecified in USA (Parenteral) (SOLA Biosciences pipeline, July 2023)